These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 427687)

  • 1. Porphyria cutanea tarda: clinical and laboratory features.
    Sweeney GD; Jones KG
    Can Med Assoc J; 1979 Apr; 120(7):803-7. PubMed ID: 427687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porphyria cutanea tarda: comparison of cases precipitated by alcohol and estrogens.
    Haberman HF; Rosenberg F; Menon IA
    Can Med Assoc J; 1975 Oct; 113(7):653-5. PubMed ID: 1181022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda.
    Felsher BF; Carpio NM; Engleking DW; Nunn AT
    N Engl J Med; 1982 Apr; 306(13):766-9. PubMed ID: 7062951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phlebotomy treatment of porphyria cutanea tarda.
    Lundvall O
    Acta Derm Venereol Suppl (Stockh); 1982; 100():107-18. PubMed ID: 6962627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron.
    Siersema PD; Rademakers LH; Cleton MI; ten Kate FJ; de Bruijn WC; Marx JJ; Wilson JH
    J Hepatol; 1995 Sep; 23(3):259-67. PubMed ID: 8550989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of serum ferritin in porphyria cutanea tarda. A reliable sign of hepatic siderosis].
    Gibertini P; Rocchi E; Cassanelli M; Pietrangelo A; Coppini M; Ventura E
    Minerva Med; 1984 Mar; 75(9-10):469-74. PubMed ID: 6709223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the results of phlebotomy therapy and low-dose chloroquine treatment in porphyria cutanea tarda.
    Malina L; Chlumský J
    Acta Derm Venereol; 1981; 61(4):346-50. PubMed ID: 6173993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection.
    Moran MJ; Fontanellas A; Brudieux E; Hombrados I; de Ledinghen V; Couzigou P; de Verneuil H; De Salamanca RE
    Hepatology; 1998 Feb; 27(2):584-9. PubMed ID: 9462661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of treatment of porphyria cutanea tarda with bloodletting and chloroquine].
    Seubert S; Seubert A; Stella AM; Guzman H; Batlle A
    Z Hautkr; 1990 Mar; 65(3):223-5. PubMed ID: 2339575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quantitative liver function tests in porphyria cutanea tarda: improvement under therapeutic phlebotomy].
    Meister F; Reichen J
    Schweiz Med Wochenschr; 1986 Mar; 116(11):341-5. PubMed ID: 3961453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red-cell uroporphyrinogen decarboxylase activity in porphyria cutanea tarda and in other forms of porphyria.
    Felsher BF; Norris ME; Shih JC
    N Engl J Med; 1978 Nov; 299(20):1095-8. PubMed ID: 703786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of porphyria cutanea tarda by venesection.
    Ramsay CA; Magnus IA; Turnbull A; Baker H
    Q J Med; 1974 Jan; 43(169):1-24. PubMed ID: 4822971
    [No Abstract]   [Full Text] [Related]  

  • 13. An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity.
    Kushner JP; Barbuto AJ; Lee GR
    J Clin Invest; 1976 Nov; 58(5):1089-97. PubMed ID: 993332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diet and alcohol effects on the manifestation of hepatic porphyrias.
    Cripps DJ
    Fed Proc; 1987 Apr; 46(5):1894-900. PubMed ID: 3556614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination therapy of porphyria cutanea tarda using chloroquine and bloodletting therapy].
    Horkay I; Nagy E
    Z Hautkr; 1980 Jun; 55(12):813-6. PubMed ID: 7415362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyria cutanea tarda in association with hemosiderosis of the liver. Iron absorption studies and evaluation of therapy by phlebotomy.
    Strickland GT
    Am J Gastroenterol; 1968 Sep; 50(3):202-7. PubMed ID: 5677557
    [No Abstract]   [Full Text] [Related]  

  • 17. Porphyria cutanea tarda, or the uroporphyrinogen decarboxylase deficiency diseases.
    Sweeney GD
    Clin Biochem; 1986 Feb; 19(1):3-15. PubMed ID: 3513989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical findings in porphyria cutanea tarda].
    Heilmann E; Vakilzadeh F
    Fortschr Med; 1977 Mar; 95(10):659-61. PubMed ID: 844765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloroquine in treatment of porphyria cutanea tarda. Long-term efficacy of combined phlebotomy and high-dose chloroquine therapy.
    Wennersten G; Ros AM
    Acta Derm Venereol Suppl (Stockh); 1982; 100():119-23. PubMed ID: 6962628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACQUIRED PORPHYRIA CUTANEA TARDA: REPORT OF A CASE SUCCESSFULLY TREATED BY PHLEBOTOMY.
    KOVAL A; DANBY CW; PETERMANN H
    Can Med Assoc J; 1965 Sep; 93(10):537-40. PubMed ID: 14341652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.